1,2-Aminoalcohol Lipidoids (II)
Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.
Researchers
-
aminoalcohol lipidoids and uses thereof
United States of America | Granted | 8,450,298 -
aminoalcohol lipidoids and uses thereof
United States of America | Granted | 8,969,353 -
no longer use - forrester id to use: 125694
India | Pending -
no longer use - forrester id to use: 125878
Mexico | Issued | 328,428 -
1,2-aminoalcohol lipidoids (ii)
Hong Kong | Pending -
no longer use - forrester id to use: 125880
Mexico | Pending -
aminoalcohol lipidoids and uses therefore
United States of America | Granted | 10,189,802 -
aminoalcohol lipidoids and uses thereof
Austria | Issued | 906,128 -
aminoalcohol lipidoids and uses thereof
Belgium | Issued | 2,365,962 -
aminoalcohol lipidoids and uses thereof
Bulgaria | Issued | 2,365,962 -
aminoalcohol lipidoids and uses thereof
Switzerland | Allowed -
aminoalcohol lipidoids and uses thereof
Czech Republic | Allowed | 2,365,962 -
aminoalcohol lipidoids and uses thereof
Denmark | Allowed -
aminoalcohol lipidoids and uses thereof
Estonia | Allowed -
aminoalcohol lipidoids and uses thereof
Finland | Issued | 0 -
aminoalcohol lipidoids and uses thereof
Greece | Allowed -
aminoalcohol lipidoids and uses thereof
Croatia | Allowed -
aminoalcohol lipidoids and uses thereof
Hungary | Allowed -
aminoalcohol lipidoids and uses thereof
Ireland | Issued | 2,365,962 -
aminoalcohol lipidoids and uses thereof
Iceland | Issued | 0 -
aminoalcohol lipidoids and uses thereof
Lithuania | Allowed -
aminoalcohol lipidoids and uses thereof
Luxembourg | Issued | 0 -
aminoalcohol lipidoids and uses thereof
Monaco | Issued | 0 -
aminoalcohol lipidoids and uses thereof
Northern Macedonia | Allowed -
aminoalcohol lipidoids and uses thereof
Netherlands | Issued | 0 -
aminoalcohol lipidoids and uses thereof
Norway | Allowed -
aminoalcohol lipidoids and uses thereof
Poland | Allowed -
aminoalcohol lipidoids and uses thereof
Portugal | Allowed -
aminoalcohol lipidoids and uses thereof
Romania | Allowed -
aminoalcohol lipidoids and uses thereof
Sweden | Allowed -
aminoalcohol lipidoids and uses thereof
Slovenia | Allowed -
aminoalcohol lipidoids and uses thereof
Slovakia | Allowed -
aminoalcohol lipidoids and uses thereof
San Marino | Allowed -
aminoalcohol lipidoids and uses thereof
Turkey | Allowed -
aminoalcohol lipidoids and uses thereof
United States of America | Granted | 10,844,028 -
aminoalcohol lipidoids and uses thereof
United States of America | Granted | 11,414,393
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.